PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 21 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $195,821 | +39.3% | 200,000 | 0.0% | 0.10% | +32.0% |
| Q1 2023 | $140,574 | +80228.0% | 200,000 | 0.0% | 0.08% | -23.5% |
| Q4 2022 | $175 | -99.9% | 200,000 | 0.0% | 0.10% | -6.7% |
| Q3 2022 | $178,000 | +4.7% | 200,000 | 0.0% | 0.10% | +8.2% |
| Q2 2022 | $170,000 | -4.0% | 200,000 | 0.0% | 0.10% | +11.5% |
| Q1 2022 | $177,000 | -3.3% | 200,000 | 0.0% | 0.09% | -1.1% |
| Q4 2021 | $183,000 | +5.2% | 200,000 | 0.0% | 0.09% | -4.3% |
| Q3 2021 | $174,000 | – | 200,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 9,000,000 | $8,848,843 | 5.74% |
| PenderFund Capital Management Ltd. | 13,010,000 | $17,187 | 5.34% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 34,893,000 | $34,151,524 | 1.50% |
| DeepCurrents Investment Group LLC | 18,721,000 | $18,288,226 | 0.72% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 25,000,000 | $24,375,000 | 0.51% |
| WATER ISLAND CAPITAL LLC | 4,750,000 | $4,686 | 0.44% |
| Westchester Capital Management, LLC | 5,150,000 | $5,092,028 | 0.16% |
| L & S Advisors Inc | 935,000 | $915,463 | 0.12% |
| Sculati Wealth Management, LLC | 200,000 | $195,821 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,368,000 | $3,298,019 | 0.09% |